Ramsay Générale de (GDS) | Financial Analysis & Statements
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
5.0B
Gross Profit
3.9B
78.75%
Operating Income
184.2M
3.68%
Net Income
-36.7M
-0.73%
EPS (Diluted)
-€0.49
Balance Sheet Metrics
Total Assets
6.9B
Total Liabilities
5.7B
Shareholders Equity
1.2B
Debt to Equity
4.61
Cash Flow Metrics
Operating Cash Flow
192.9M
Free Cash Flow
418.3M
Revenue & Profitability Trend
Ramsay Générale de Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5.0B | 4.7B | 4.3B | 4.0B | 3.7B |
| Cost of Goods Sold | 1.1B | 978.8M | 890.7M | 818.6M | 731.6M |
| Gross Profit | 3.9B | 3.7B | 3.4B | 3.2B | 3.0B |
| Operating Expenses | 678.9M | 516.3M | 749.1M | 704.3M | 633.1M |
| Operating Income | 184.2M | 218.2M | 293.7M | 265.9M | 184.7M |
| Pre-tax Income | -40.8M | 87.7M | 185.2M | 103.3M | 45.2M |
| Income Tax | -4.1M | 23.8M | 57.3M | 29.5M | 27.1M |
| Net Income | -36.7M | 63.9M | 127.8M | 73.8M | 18.1M |
| EPS (Diluted) | -€0.49 | €0.45 | €1.07 | €0.59 | €0.12 |
Income Statement Trend
Ramsay Générale de Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.5B | 1.4B | 1.3B | 1.5B | 1.6B |
| Non-Current Assets | 5.4B | 5.6B | 5.5B | 5.2B | 5.2B |
| Total Assets | 6.9B | 7.0B | 6.8B | 6.7B | 6.7B |
| Liabilities | |||||
| Current Liabilities | 1.7B | 1.5B | 1.5B | 1.6B | 1.6B |
| Non-Current Liabilities | 4.0B | 4.2B | 4.1B | 4.0B | 4.1B |
| Total Liabilities | 5.7B | 5.7B | 5.5B | 5.6B | 5.7B |
| Equity | |||||
| Total Shareholders Equity | 1.2B | 1.3B | 1.2B | 1.1B | 1.0B |
Balance Sheet Composition
Ramsay Générale de Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -36.7M | 63.9M | 127.8M | 73.8M | 18.1M |
| Operating Cash Flow | 192.9M | 220.2M | -123.3M | 228.5M | 440.8M |
| Investing Activities | |||||
| Capital Expenditures | -166.6M | -165.1M | -175.4M | -173.9M | -164.1M |
| Investing Cash Flow | -180.9M | -176.5M | -471.8M | -182.0M | -186.7M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 41.7M | 189.5M | 87.6M | -61.4M | -61.4M |
| Free Cash Flow | 418.3M | 426.7M | 68.9M | 475.9M | 560.9M |
Cash Flow Trend
Ramsay Générale de Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.13
Price to Book
1.08
Price to Sales
0.24
PEG Ratio
-0.16
Profitability Ratios
Profit Margin
-1.55%
Operating Margin
2.41%
Return on Equity
-5.16%
Return on Assets
1.48%
Financial Health
Current Ratio
0.80
Debt to Equity
337.92
Beta
0.18
Per Share Data
EPS (TTM)
-€0.72
Book Value per Share
€10.21
Revenue per Share
€46.61
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| gds | 1.2B | 34.13 | 1.08 | -5.16% | -1.55% | 337.92 |
| Sopra Steria | 4.0B | 13.27 | 2.08 | 16.28% | 4.34% | 62.25 |
| Alten S.A | 2.4B | 13.15 | 1.10 | 8.78% | 4.50% | 16.78 |
| Société Générale | 37.4B | 8.50 | 0.53 | 4.37% | 19.91% | 4.05 |
| Capgemini SE | 24.7B | 14.97 | 2.05 | 15.06% | 7.56% | 51.68 |
| Infotel | 270.9M | 14.75 | 2.19 | 15.62% | 6.27% | 24.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.